Suvretta Capital Management, Llc - Apr 22, 2024 Form 3 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
10%+ Owner
Signature
By: /s/Andrew Nathanson, Suvretta Capital Management, LLC, General Counsel & Chief Compliance Officer
Stock symbol
BNTC
Transactions as of
Apr 22, 2024
Transactions value $
$0
Form type
3
Date filed
5/2/2024, 05:27 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BNTC Common stock, par value $0.0001 per share 1.47M Apr 22, 2024 I F1, F2, F4
holding BNTC Common stock, par value $0.0001 per share 221K Apr 22, 2024 I F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BNTC Pre-Funded Warrants Apr 22, 2024 Common Stock 588K $0.00 I F5, F6, F11, F12
holding BNTC Pre-Funded Warrants Apr 22, 2024 Common Stock 4.61M $0.00 I F5, F7, F11, F12
holding BNTC Pre-Funded Warrants Apr 22, 2024 Common Stock 1.73M $0.00 I F5, F8, F11, F12
holding BNTC Pre-Funded Warrants Apr 22, 2024 Common Stock 576K $0.00 I F5, F9, F11, F12
holding BNTC Pre-Funded Warrants Apr 22, 2024 Common Stock 276K $0.00 I F5, F10, F11, F12
holding BNTC Series 2 Common Warrants Apr 22, 2024 Common Stock 588K $1.93 I F6, F11, F12
holding BNTC Common Warrants Apr 22, 2024 Common Stock 4.61M $3.86 I F7, F11, F12
holding BNTC Common Warrants Apr 22, 2024 Common Stock 576K $3.86 I F9, F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 See Exhibit 99.1
F2 See Exhibit 99.1
F3 See Exhibit 99.1
F4 See Exhibit 99.1
F5 See Exhibit 99.1
F6 See Exhibit 99.1
F7 See Exhibit 99.1
F8 See Exhibit 99.1
F9 See Exhibit 99.1
F10 See Exhibit 99.1
F11 See Exhibit 99.1
F12 See Exhibit 99.1

Remarks:

Exhibit List: ------------- Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signatures